Advanced search
Publication Cover
Leukemia & Lymphoma Volume 64, 2023 - Issue 8
Submit an article Journal homepage
88
Views
0
CrossRef citations to date
0
Altmetric
Letters to the Editor

Time to first transfusion in lower-risk patients with myelodysplastic neoplasia (MDS) is another prognostic factor of survival

Hans Tilman Steinmetza Outpatient Clinics for Hematology and Oncology, Cologne, GermanyCorrespondence[email protected]
View further author information
,
J. Toczek-Thiela Outpatient Clinics for Hematology and Oncology, Cologne, GermanyView further author information
,
J. Lipkeb Outpatient Clinics for Hematology and Oncology, Dortmund, GermanyView further author information
,
R. Lierschc Outpatient Clinics for Hematology and Oncology, Münster, GermanyView further author information
,
A. Sauerd Outpatient Clinics for Hematology and Oncology, Potsdam, GermanyView further author information
,
H. Tesche Outpatient Clinics for Hematology and Oncology, Frankfurt/Main, GermanyView further author information
,
J. Heßlingf Outpatient Clinics for Hematology and Oncology, Berlin, GermanyView further author information
,
U. Totzkeg TDS, Basel, SwitzerlandView further author information
&
S. Schmitza Outpatient Clinics for Hematology and Oncology, Cologne, GermanyView further author information
 show all
Pages 1476-1479 | Received 01 Mar 2023, Accepted 10 May 2023, Published online: 31 May 2023
 
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days
Click to increase image sizeClick to decrease image sizeFree first page

Acknowledgements

This registry was granted by Celgene and Novartis. We thank M. Hellmich (Institute of Medical Statistics and Computational Biology, Cologne, Germany) for statistical support and all participating hematologists for the contribution of data.

Disclosure statement

The authors report no conflicts of interest.

Additional information

Funding

The author(s) reported there is no funding associated with the work featured in this article.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.